Group One Trading’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Group One Trading’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-174	Closed	-$37	–	8177
2024 Q3	$37	Hold	174	–	–	﹤0.01%	6507
2024 Q2	$40	Sell	174 -100	-36%	-$60	﹤0.01%	6576
2024 Q1	$228	Buy	274 +78	+40%	+$53	﹤0.01%	6800
2023 Q4	$76	Sell	196 -800	-80%	-$638	﹤0.01%	7211
2023 Q3	$1.59K	Buy	+996	New	+$2.75K	﹤0.01%	7112
2021 Q3	–	Sell	-2,641	Closed	-$68.2K	–	8926
2021 Q2	$82K	Buy	2,641 +177	+7%	+$5.3K	﹤0.01%	6155
2021 Q1	$63K	Buy	+2,464	New	+$61.8K	﹤0.01%	6063

Other funds holding RNLX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

IIC

Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Group One Trading's RNLX Position: Q4 2024 in Review

Group One Trading sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 174 shares — an estimated $37 sold.

Group One Trading first reported a position in RNLX in Q1 2021 and held it in 7 quarters. The position peaked at $82K in Q2 2021. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

Group One Trading reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Group One Trading sold 174 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $37.
Group One Trading first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 7 quarters.
Group One Trading's Renalytix plc American Depositary Shares position peaked at $82K in Q2 2021.
3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.